CIRCULATING MIR-625-3P: A POTENTIAL BIOMARKER FOR MALIGNANT PLEURAL MESOTHELIOMA

被引：0
|
作者：
Kirschner, M. B. [1 ]
Cheng, Y. Y. [1 ]
Badrian, B. [2 ,3 ]
Kao, S. C. [1 ,4 ]
Creaney, J. [5 ,6 ]
Edelman, J. J. B. [7 ,8 ]
Harvie, R. [9 ,10 ]
Armstrong, N. J. [11 ,12 ]
Vallely, M. P. [7 ,8 ]
Musk, A. W. [5 ,6 ,13 ]
Robinson, B. W. S. [5 ,6 ]
McCaughan, B. C. [7 ,8 ]
Pavlakis, N. [9 ,10 ]
Klebe, S. [14 ]
Mutsaers, S. E. [2 ,3 ]
van Zandwijk, N. [1 ]
Reid, G. [1 ]
机构：
[1] Univ Sydney, Asbestos Dis Res Inst, Sydney, NSW 2006, Australia
[2] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Lung Inst Western Australia, Nedlands, WA 6009, Australia
[3] Univ Western Australia, Pathwest Labs Med, Nedlands, WA 6009, Australia
[4] Concord Hosp, Dept Med Oncol, Sydney, NSW, Australia
[5] Univ Western Australia, Sch Med & Pharmacol, Natl Res Ctr Asbestos Related Dis, Nedlands, WA 6009, Australia
[6] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia
[7] Univ Sydney, Royal Prince Alfred Hosp, Cardiothorac Surg Unit, Baird Inst, Sydney, NSW 2006, Australia
[8] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia
[9] Univ Sydney, Royal N Shore Hosp, Bill Walsh Canc Res Labs, Kolling Inst Med Res, Sydney, NSW 2006, Australia
[10] Univ Sydney, Royal N Shore Hosp, Dept Med Oncol, Sydney, NSW 2006, Australia
[11] Univ New S Wales, Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2052, Australia
[12] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia
[13] Univ Western Australia, Dept Populat Hlth, Nedlands, WA 6009, Australia
[14] Flinders Med Ctr, Dept Anat Pathol, Adelaide, SA, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S174 / S174
页数：1
相关论文
共 50 条
  • [21] Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study
    Hoda, Mir Alireza
    Dong, Yawen
    Rozsas, Anita
    Klikovits, Thomas
    Laszlo, Viktoria
    Ghanim, Bahil
    Stockhammer, Paul
    Ozsvar, Judit
    Jakopovic, Marko
    Samarzija, Miroslav
    Brcic, Luka
    Bendek, Matyas
    Szirtes, Ildiko
    Reid, Glen
    Kirschner, Michaela B.
    Kao, Steven C.
    Opitz, Isabelle
    Weder, Walter
    Frauenfelder, Thomas
    Thi Dan Linh Nguyen-Kim
    Aigner, Clemens
    Klepetko, Walter
    van Zandwijk, Nico
    Berger, Walter
    Dome, Balazs
    Grusch, Michael
    Hegedus, Balazs
    EUROPEAN JOURNAL OF CANCER, 2016, 63 : 64 - 73
  • [22] MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p
    Wang, Pei
    Bai, Cuiwei
    Shen, Shasha
    Jiang, Chang
    Deng, Jie
    Han, Dan
    OPEN MEDICINE, 2021, 16 (01): : 1653 - 1667
  • [23] Cell-Free MicroRNA miR-625-3p Is Elevated in the Blood of Patients with Thoracic Malignancies
    Kirschner, Michaela B.
    Williams, Marissa
    Burgers, Sjaak
    Hoda, Mir A.
    Korse, Catharina M.
    Van den Broek, Daan
    Klikovits, Thomas
    Hegedus, Balazs
    Dome, Balazs
    Grusch, Michael
    Klepetko, Walter
    Van Zandwijk, Nico
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S350 - S350
  • [24] miR-625-3p在卵巢浆液性癌中的表达及意义
    王莉
    蔡旺
    中国医科大学学报, 2020, 49 (02) : 139 - 143
  • [25] Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
    Weber, Daniel G.
    Casjens, Swaantje
    Johnen, Georg
    Bryk, Oleksandr
    Raiko, Irina
    Pesch, Beate
    Kollmeier, Jens
    Bauer, Torsten T.
    Bruening, Thomas
    PLOS ONE, 2014, 9 (12):
  • [26] Circulating miR-625 as an Emerging Biomarker for Liver Cirrhosis
    Ghaempoor, Mohabbat
    Arefian, Ehsan
    Mohebbi, Seyed R.
    Shanaki, Mehrnoosh
    Kazerouni, Faranak
    Hatami, Behzad
    CLINICAL LABORATORY, 2019, 65 (04) : 453 - 459
  • [27] miR-625-3p enhances chemosensitivity in ovarian cancer cells through exosomal export of cisplatin and paclitaxel
    Yeung, Chi Lam Au
    Tsuruga, Tetsushi
    Yip, Kay-Pong
    Ferri-Borgogno, Sammy
    Mok, Samuel
    CANCER RESEARCH, 2022, 82 (12)
  • [28] MESOMARK™:: A potential test for malignant pleural mesothelioma
    Beyer, Heather L.
    Geschwindt, Ryan D.
    Glover, Curtis L.
    Tran, Ly
    Hellstrom, Ingegerd
    Hellstrom, Karl-Erik
    Miller, M. Craig
    Verch, Thorsten
    Allard, W. Jeffrey
    Pass, Harvey I.
    Sardesai, Niranjan Y.
    CLINICAL CHEMISTRY, 2007, 53 (04) : 666 - 672
  • [29] Diagnostic potential of microRNAs in malignant pleural mesothelioma
    Andersen, M.
    Grauslund, M.
    Ravn, J.
    Sorensen, J. B.
    Andersen, C. B.
    Santoni-Rugiu, E.
    APMIS, 2012, 120 : 17 - 17
  • [30] Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
    Yang, Haitang
    Xu, Duo
    Schmid, Ralph A.
    Peng, Ren-Wang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
12345